Tilmovet 40 g/kg Premix for medicated feeding stuff for pigs and rabbits

Země: Irsko

Jazyk: angličtina

Zdroj: HPRA (Health Products Regulatory Authority)

Aktivní složka:

Tilmicosin

Dostupné s:

Huvepharma NV

ATC kód:

QJ01FA91

INN (Mezinárodní Name):

Tilmicosin

Dávkování:

40 gram(s)/kilogram(s)

Léková forma:

Premix for medicated feeding stuff

Druh předpisu:

POM: Prescription Only Medicine as defined in relevant national legislation

Terapeutické skupiny:

Porcine, Rabbits

Terapeutické oblasti:

tilmicosin

Terapeutické indikace:

Antibacterial

Stav Autorizace:

Authorised

Datum autorizace:

2009-02-13

Charakteristika produktu

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Tilmovet 40 g/kg Premix for medicated feeding stuff for pigs and
rabbits
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substance: 40 g tilmicosin per kg
Excipients:
For the full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Premix for medicated feeding stuff
A yellowish tan to reddish tan free-flowing granular material.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs (weaned piglets and fattening pigs) and rabbits.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Pigs:
Prevention and treatment of respiratory disease caused by_
Actinobacillus pleuropneumoniae, Mycoplasma_
_hyopneumoniae, Pasteurella multocida_ and other organisms sensitive
to tilmicosin.
Rabbits:
Prevention and treatment
of
respiratory disease caused by_ Pasteurella multocida_ and_ Bordetella
bronchiseptica_,
susceptible to tilmicosin.
4.3 CONTRAINDICATIONS
Horses or other_ Equidae_, must not be allowed access to feeds
containing tilmicosin. Horses fed with tilmicosin
medicated feeds may present signs of toxicity with lethargy, anorexia,
reduction of feed consumption, loose stools,
colic, distension of the abdomen and death.
Do not use in case of hypersensitivity to tilmicosin or to any of the
excipients.
Do not use in animals hypersensitive to tilmicosin and when there is
resistance to tilmicosin or cross resistance to other
macrolides like tylosin, erythromycin or lincomycin.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
With regard to the management of respiratory disease outbreaks, it
should be noted that acutely ill animals are likely to
be inappetant and therefore require parenteral treatment.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___